Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

27.39
+0.85003.20%
Pre-market: 27.10-0.2900-1.06%07:22 EDT
Volume:4.79M
Turnover:129.34M
Market Cap:10.59B
PE:-2.95
High:27.41
Open:26.66
Low:26.33
Close:26.54
Loading ...

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Solid Biosciences (SLDB) and Moderna (MRNA)

TIPRANKS
·
25 Feb

Moderna Inc. Stock Slips 4.6%, Underperforms Competitors

Dow Jones
·
25 Feb

Stock Track | Moderna Plummets 6.26% as International Revenue Disappoints

Stock Track
·
25 Feb

Moderna Shares Down 4.8% After Over 5% Gain in Previous Session

THOMSON REUTERS
·
24 Feb

Moderna (MRNA) International Revenue Performance Explored

Zacks
·
24 Feb

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Zacks
·
24 Feb

Moderna Shares Down 2.9% Premarket

THOMSON REUTERS
·
24 Feb

Moderna’s 2024 Struggles: Navigating Commercial Challenges and Market Competition in the Vaccine Industry

TIPRANKS
·
22 Feb

Why Moderna Inc. (MRNA) Surged On Friday?

Insider Monkey
·
22 Feb

Chinese researchers find bat virus enters human cells via same pathway as COVID

Reuters
·
22 Feb

Moderna Inc. Stock Climbs 5.3%, Outperforms Competitors

Dow Jones
·
22 Feb

UBS Adjusts Moderna Price Target to $78 From $96, Maintains Buy Rating

MT Newswires Live
·
19 Feb

Moderna Is Maintained at Buy by UBS

Dow Jones
·
19 Feb

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Zacks
·
19 Feb

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

Business Wire
·
19 Feb

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Yahoo Finance
·
19 Feb

Why Moderna (MRNA) Went Up on Tuesday?

Insider Monkey
·
19 Feb

Moderna Inc. Stock Climbs 8.4%, Outperforms Competitors

Dow Jones
·
19 Feb

Why Moderna (MRNA) Stock Is Up Today

StockStory
·
19 Feb

Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges

Benzinga
·
19 Feb